Literature DB >> 25280705

Synthesis of novel core-shell structured dual-mesoporous silica nanospheres and their application for enhancing the dissolution rate of poorly water-soluble drugs.

Chao Wu1, Xiaohu Sun2, Zongzhe Zhao3, Ying Zhao3, Yanna Hao3, Ying Liu3, Yu Gao4.   

Abstract

Novel core-shell dual-mesoporous silica nanospheres (DMSS) with a tunable pore size were synthesized successfully using a styrene monomer as a channel template for the core and cetyltrimethyl ammonium bromide (CTAB) as a channel template for the shell in order to improve the dissolution rate of poorly water-soluble drugs. Simvastatin was used as a model drug and loaded into DMSS and the mesoporous core without the shell (MSC) by the solvent evaporation method. The drug loading efficiency of DMSS and MSC were determined by thermogravimetric analysis (TGA) and ultraviolet spectroscopy (UV). Characterization, using scanning electron microscopy (SEM), transmission electron microscopy (TEM), nitrogen adsorption, powder X-ray diffraction (XRD), differential scanning calorimetry (DSC), and Fourier transform infrared spectroscopy (FTIR) showed that simvastatin adsorbed in DMSS and MSC was in an amorphous state, and in vitro release test results demonstrated that both DMSS and MSC increased the water solubility and dissolution rate of simvastatin. The shell structure of DMSS was able to regulate the release of simvastatin compared with MSC. It is worth noting that DMSS has significant potential as a carrier for improving the dissolution of poorly water-soluble drugs and reducing the rapid release.
Copyright © 2014 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Core-shell dual-mesoporous silica nanosphere (DMSS); Poorly water-soluble drugs; Simvastatin

Mesh:

Substances:

Year:  2014        PMID: 25280705     DOI: 10.1016/j.msec.2014.08.040

Source DB:  PubMed          Journal:  Mater Sci Eng C Mater Biol Appl        ISSN: 0928-4931            Impact factor:   7.328


  5 in total

1.  Sulfonic Acid Derivative-Modified SBA-15, PHTS and MCM-41 Mesoporous Silicas as Carriers for a New Antiplatelet Drug: Ticagrelor Adsorption and Release Studies.

Authors:  Michał Moritz; Małgorzata Geszke-Moritz
Journal:  Materials (Basel)       Date:  2020-06-29       Impact factor: 3.623

2.  Hyaluronic Acid-Functionalized Mesoporous Silica Nanoparticles Loading Simvastatin for Targeted Therapy of Atherosclerosis.

Authors:  Kechen Song; Zhuang Tang; Zhiling Song; Shiyu Meng; Xiaoxue Yang; Hui Guo; Yizhun Zhu; Xiaolin Wang
Journal:  Pharmaceutics       Date:  2022-06-14       Impact factor: 6.525

3.  Development of a tin oxide carrier with mesoporous structure for improving the dissolution rate and oral relative bioavailability of fenofibrate.

Authors:  Andi Bai; Chao Wu; Xuan Liu; Huiling Lv; Xiaoyan Xu; Yue Cao; Wenjing Shang; Lili Hu; Ying Liu
Journal:  Drug Des Devel Ther       Date:  2018-07-10       Impact factor: 4.162

4.  Folic acid-conjugated mesoporous silica particles as nanocarriers of natural prodrugs for cancer targeting and antioxidant action.

Authors:  Khaled AbouAitah; Anna Swiderska-Sroda; Ahmed A Farghali; Jacek Wojnarowicz; Agata Stefanek; Stanislaw Gierlotka; Agnieszka Opalinska; Abdou K Allayeh; Tomasz Ciach; Witold Lojkowski
Journal:  Oncotarget       Date:  2018-05-29

5.  Pure paclitaxel nanoparticles: preparation, characterization, and antitumor effect for human liver cancer SMMC-7721 cells.

Authors:  Chao Wu; Yu Gao; Ying Liu; XiaoYan Xu
Journal:  Int J Nanomedicine       Date:  2018-10-09
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.